Acanthosis nigricans in a patient treated with palifermin
Lee, M.; Grassi, M.
Cutis 86(3): 136-137
2010
ISSN/ISBN: 0011-4162 PMID: 21049730 Document Number: 639414
Palifermin is a modified human keratinocyte growth factor (KGF) given to decrease the incidence and duration of severe oral mucositis in patients receiving myelotoxic chemotherapy followed by a hematopoietic stem cell transplant. We report a case of a 42-year-old man who developed acanthosis nigricans after taking palifermin.